![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_c7416e1543ca26168b769dc25d1f2310.svg) | Tetracaine | IC50 | 400.0 [1], 3400.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_82e6e72d4015f4317c9dcf0a9bbd6f2e.svg) | Brevetoxin B | IC50 | 15.02 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_65afb76c3a578811e6361184e0e4bec6.svg) | Truncated brevetoxin B | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_0eef56c0e8fcd434d580b92c8bcad573.svg) | Cocaine | IC50 | 49000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_bec8eaadb51e755de26c3660866564ee.svg) | Caffeine | IC50 | 660000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_32a0612a648044dbc4831a7d07460b80.svg) | Dexpropranolol | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_dc3b519ae4da383d84a5502ee939a5d0.svg) | Lidocaine | IC50 | 240000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_01814a6086009d7440d5f435a324c600.svg) | Verapamil | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_caf22049175650885f1cb5baf186790e.svg) | Forskolin | IC50 | 60000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_3263da23dd579767016d0f254e73b6f9.svg) | Phenobarbital | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_444fa0db37706d6efa6c25fb3dd7c1de.svg) | Phenytoin | IC50 | 18500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_858e87a6c2598795bd2c427f6df41432.svg) | Bupivacaine | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_a7e11d7bcee94c9af8c42c557a082c25.svg) | Chlorpromazine | IC50 | 4300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1232c84d43d4865ebdc5de8d7663a19f.svg) | Nifedipine | IC50 | 37000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_8eea222a1bcb2e74405ba02fe4c3db74.svg) | Reserpine | IC50 | 1600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_48ea7a4994504f9b219236eee6a49ed6.svg) | Procaine | IC50 | 110000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_6c3911c895bcf58e15c1ea316421d8fe.svg) | Imipramine | IC50 | 3600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | IC50 | 10100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_3fb59b292039fb68c21d347565286601.svg) | Quinine | IC50 | 4400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_946b0b501eb57b26c13e79111c2b1587.svg) | Amitriptyline | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | IC50 | 8400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1651d7921a8facf41c6a5623ae7707ce.svg) | Diltiazem | IC50 | 45000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_b7b8a734145b81caa9a4a7ab9953506c.svg) | Metoprolol | IC50 | 117000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_d9d88c2a7bdabc45b702c06047b28bae.svg) | Quinidine | IC50 | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_fac222a9fee62d9cda063e5aabf1d4d4.svg) | 3-Isobutyl-1-methylxanthine | IC50 | 1800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_b2f3218cdbd5f04949eaaf044a21d56f.svg) | Desipramine | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_db73eda68e8c605bf06d779827ec4e13.svg) | Strychnine | IC50 | 21000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_103d6bbd657edee7a15807dc04059e08.svg) | Diphenhydramine | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_c3fec52b171093040a67f2fb6c9d8f8e.svg) | Phenoxybenzamine | IC50 | 45000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_3b2da37f0b0ee76d72c81525a0edc58c.svg) | Clomipramine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_fdc8decca39cd6032261f9e59badc53b.svg) | Quinacrine | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_25e00ddcefac263e91f92959ff7dec3c.svg) | Trifluoperazine | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_75b4a3ad6d84cdf5a40e35cf9ff23287.svg) | Promethazine | IC50 | 6900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | IC50 | 5500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_f25dfa08591eac4ad2095b30ced84e29.svg) | Spiperone | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_84bb916240e50717d31fff4e0ed5efcf.svg) | Prilocaine | IC50 | 54000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_7453ac4617d624197c82d5878d87f141.svg) | Droperidol | IC50 | 740.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_6833af5a00e4820a7dec88d7ed0f4ead.svg) | Thioridazine | IC50 | 6500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_53e0258413dfe8503285a6d017480c2b.svg) | Fluphenazine | IC50 | 3700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_b43dfbf8c70b45c06b22f8e861f610cd.svg) | Nortriptyline | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_cb750002dee58d561d94983204db8910.svg) | Cyproheptadine | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_a51b30f2494a45cccba6c8c3f14d39bb.svg) | Nitrendipine | IC50 | 36000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_aaf3fd234b0a01481a8025379dd6f784.svg) | Chlorpheniramine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_84d4469c2b25f634938bff679377ae62.svg) | Loperamide | IC50 | 270.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_51c708c974941839b8db7c555709b62e.svg) | Benzocaine | IC50 | 910000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_4aec11d77ecb315794fbcc0f401f0cfe.svg) | Tetrabenazine | IC50 | 85000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_c03548f44c098385f9d74e3def74a9a4.svg) | Proadifen | IC50 | 4200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_7455329d29e2aded85fa5903499a5b22.svg) | Hydroxyzine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1c616b6d41cb337e09c0b8191fddc465.svg) | Felodipine | IC50 | 37000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_f4df25a7afebf1dbe9c187a14c4ccbb0.svg) | Promazine | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_6541e58d34a9457ec45aabc9cdd8aef7.svg) | Flunarizine | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_651e93ab94925b96a9fd90c4ef0d6a82.svg) | Doxepin | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_0b0ec958d081ebdeab2bf564d1648673.svg) | Dibucaine | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_e4d51706ccafae108b5baa824e5faa47.svg) | Gallopamil | IC50 | 3600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_4e787c15d05c81e9c577c24aa928fd0f.svg) | Bepridil | IC50 | 840.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_89204000491e48a54045d07bf3547c1f.svg) | Nisoldipine | IC50 | 26000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_ecc4be71f3156977c4d4315002ef2e79.svg) | Cinnarizine | IC50 | 440.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_8da77bd1f8802d0742140cb4ceb0b7da.svg) | 1-[(7-Methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)-2-butanol | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_094e7e30c7002c13aed1af08d7fd4471.svg) | Articaine | IC50 | 51000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_c080ac9d905e84e7b51f62f7fb555550.svg) | Biperiden | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_2049783460830b7ebd687fa8b3f84148.svg) | Levorphanol | IC50 | 25000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_602cd641a77ba903b85b3fdb24fee22c.svg) | Chlorprothixene | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_fd283a9d0fb512e4acf6639eceaebf94.svg) | Dextrorphan | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1f85cad280214d65d509bf351be9b445.svg) | Prenylamine | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1da7796636ac353dc2208e75058f9634.svg) | Proparacaine | IC50 | 1900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_2217591288b149e5273e4fb6237a62ac.svg) | Dicyclomine | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_56894e0ae927a91f3cca3eec195f918b.svg) | Tiapamil | IC50 | 13500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_75a11d9967edc68aaa5950e2da4a75ee.svg) | Brompheniramine | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_ba542a5bc1738d2cfd8e04d577f40e69.svg) | Oxybuprocaine | IC50 | 2900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_d203255bfb0c4b27264e15eaeed0d4a7.svg) | Propoxycaine | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_f71563692c989d6e65f8d37107ed8387.svg) | Etidocaine | IC50 | 3500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_07d5cdd978e638e06866fa709f9796e9.svg) | Pheniramine | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_e1089bfa5de10a32cda95c739125cc17.svg) | Dilazep | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_a3076ad3396235271e2c4d9efc84d7c4.svg) | Protriptyline | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_572032fb3d3bef05fc2d30862cc4e78d.svg) | (+)-Butaclamol | IC50 | 3600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_f8aba9f3e7e7e52b2b80d93116b3a61f.svg) | 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_afef4b28234c0c212a5ac4be1d17343f.svg) | Butaclamolum | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_bb790620f1f8bcf1094b51f7b1f80038.svg) | Butaxamine | IC50 | 27000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_6f31aee472b22fecef258ac80a6b74d5.svg) | Piperoxan | IC50 | 61000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_405e074996d61bc414e5df3b7c1bb4dd.svg) | Dichloroisoproterenol | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_4c31add71685d9064317db7d13ef8e15.svg) | N-(6-Aminohexyl)-1-naphthalenesulfonamide Hydrochloride | IC50 | 22000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_7af600edf171aee76c22883952fabe2d.svg) | Azacyclonol | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_9a7604d7d40e34d5080383ea1efbf183.svg) | Diphenidol | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_217c91f45ea08785a1573b00ea3e240f.svg) | Oxethazaine | IC50 | 2300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_d2ead5c9f54822d8be38749ba7595b20.svg) | Hexobendine | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_8c05d6bfbdd5a932a368f26955096b2e.svg) | Pramoxine | IC50 | 21200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_d8020d674a46ddd4519d6c32c47695d2.svg) | Butacaine | IC50 | 2700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_2fc4fcf66e68db2e7597346ee62fea0a.svg) | Hexylcaine | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_aa2848cdebf918f64e9d018d270ddd0a.svg) | N-Methylpiperidin-4-yl propionate | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_adeb8ec52146131ca65e04d6e40c05ac.svg) | Dimethisoquin | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_07f7c3c4606f5c2bcaee4b763156933a.svg) | Piperocaine | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_c73c7ec65fd5ee0be6dc6a3a1118cc90.svg) | Cns-5161 | IC50 | 1750.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_ea5fe21ede9ac903ba14065f0f95f736.svg) | Cyclomethycaine | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_414a3cdd5d966a7d9235fe1256e8f610.svg) | 2-n-Butyl-3-(dimethylamino)-5,6-methylenedioxyindene | IC50 | 12500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_e324c8b62b7186713b16a7f7fa656342.svg) | Diperodon | IC50 | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_1114c67778b96c4da882c2cbedb959f7.svg) | Parethoxycaine | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_0fd201f19d557361eb944e8961deb097.svg) | N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-alpha-subunits-brain-types-i-ii-iii_84158f1eee3fe8de3559a0a2dbf710a5.svg) | 1'-(3-(Diethylamino)propyl)-3,4-dihydrospiro(naphthalene-1(2H),3'-pyrrolidine)-2',5'-dione | IC50 | 94000.0 [1] |